AMAG

AMAG Pharmaceuticals, Inc. News Headlines

$49.03
*  
0.20
0.41%
Get AMAG Alerts
*Delayed - data as of Mar. 2, 2015 13:51 ET  -  Find a broker to begin trading AMAG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMAG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AMAG Prices Offering At $44/Share
2/25/2015 7:23:00 PM - RTT News


AMAG Pharmaceuticals: The Short Thesis Is Wrong
2/18/2015 8:06:00 PM - Seeking Alpha


Lumara Shareholders Are Bailing Out. Shouldn't You?
2/17/2015 4:39:00 PM - Seeking Alpha


Earnings Reported After The Bell Feb. 9
2/10/2015 2:26:00 AM - RTT News


Triferic: The Kill Shot For AMAG Pharmaceuticals' Feraheme
1/27/2015 5:41:00 PM - Seeking Alpha


Minerva Neurosciences Gains on Positive Data on MIN-202 - Analyst Blog
1/23/2015 5:20:00 AM - Investopedia


Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog
1/22/2015 5:10:00 AM - Investopedia


Bayer Announces Updates to European Label of Xarelto - Analyst Blog
1/21/2015 6:17:00 AM - Investopedia


Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog
1/21/2015 6:13:00 AM - Investopedia


Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog
1/21/2015 6:08:00 AM - Investopedia


AMAG Pharmaceuticals - The Short Story Gets Even Better
1/20/2015 12:34:00 PM - Seeking Alpha


Actavis/Gedeon Richter Present Schizophrenia Drug Data - Analyst Blog
1/20/2015 4:30:00 AM - Investopedia


Celgene Up as Otezla Gains EU Approval for Two Indications - Analyst Blog
1/19/2015 4:30:00 AM - Investopedia


Illumina Unveils 3 NGS Systems, Modifies Business Strategy - Analyst Blog
1/16/2015 2:30:00 PM - Investopedia


Amgen (AMGN) Reveals Mixed Results from Vectibix Studies - Analyst Blog
1/16/2015 4:00:00 AM - Investopedia


Illumina Declares Impressive Q4, 2014 Preliminary Results - Analyst Blog
1/15/2015 2:40:00 PM - Investopedia


Regado Biosciences to Merge with Tobira Therapeutics - Analyst Blog
1/15/2015 2:30:00 PM - Investopedia


Vical Up on Deal with AnGes to Develop Ebola Treatment - Analyst Blog
1/15/2015 10:50:00 AM - Investopedia


AstraZeneca Announces Encouraging Data from Brilinta Study - Analyst Blog
1/15/2015 10:30:00 AM - Investopedia


Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
1/15/2015 4:30:00 AM - Investopedia


Qiagen Up on Enzymatics' Unit Buy, ArcherDX Partnership Deal - Analyst Blog
1/14/2015 2:30:00 PM - Investopedia


BioMarin Gains on Vimizim 2014 View, Batten Disease Data - Analyst Blog
1/14/2015 5:10:00 AM - Investopedia


Amgen Maintains 2015 View, Expects Several Drug Launches - Analyst Blog
1/14/2015 3:40:00 AM - Investopedia


Will Qiagen's Qiasymphony Placements Weave Magic in 2015? - Analyst Blog
1/13/2015 2:30:00 PM - Investopedia


Celgene's Preliminary Results & 2015 Outlook Encouraging - Analyst Blog
1/13/2015 7:20:00 AM - Investopedia